StreetAlpha
13F holdings · Q3 2026

Octagon Capital Advisors

New York, NY · files as Octagon Capital Advisors LP
Know the moment Octagon Capital Advisors filesYou follow Octagon Capital Advisors An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1839435

Octagon Capital Advisors reported 25 stocks worth $740M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are DNTH (20.1%), ABVX (13.3%) and DFTX (12.9%). Compared with Q2 2026, the fund opened new positions in OBX and TNGX, added to AVBP, trimmed DNTH, DFTX and KYMR and sold out of ALMS, SMMT and CNTX.

Latest filing: what Octagon Capital Advisors did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
2 new1 added13 trimmed3 sold outBought about $54M · sold about $292M
New 2
Added 1
Trimmed 13
See all 13 →
Sold out 3

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$740M−32.1% vs last quarter · $751M including options
Stocks held252 new · 3 sold out
Top 5 weight65.2%very concentrated
Turnover47%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
DNTH
Dianthus Therapeutics Inc
$149M20.1%1.7M−155K (−8%)8 of 8
2
ABVX
Abivax SA
$98.3M13.3%993KNo change7 of 8
3
DFTX
Definium Therapeutics Inc
$95.6M12.9%2.5M−439K (−15%)3 of 8
4
COGT
Cogent Biosciences Inc
$75.2M10.2%2.4MNo change8 of 8
5
AVBP
Arrivent Biopharma Inc
$64.8M8.8%2.1M+170K (+9%)8 of 8
6
TSHA
Taysha Gene Therapies Inc
$47.2M6.4%9.7MNo change8 of 8
7
OBX
Obsidian Therapeutics Inc
$33.2M4.5%2.4MNew position1 of 8
8
KYMR
Kymera Therapeutics Inc
$22.9M3.1%205K−105K (−34%)6 of 8
9
IRON
Disc Medicine Inc
$17.7M2.4%270KNo change3 of 8
10
TNGX
Tango Therapeutics Inc
$15.7M2.1%630KNew position1 of 8
🔒 15 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
ALMS
Alumis Inc
$79.7M2.8M
SMMT
Summit Therapeutics Inc
$18.2M1.3M
CNTX
Context Therapeutics Inc C
$1.7M3M

Options

valued at the underlying shares
StockTypeValueSharesChange
ERAS
Erasca Inc
Call$10.6M720K−535,000

Reported value

last 8 quarters
$588MQ4 '24
$508MQ1 '25
$456MQ2 '25
$641MQ3 '25
$799MQ4 '25
$904MQ1 '26
$1.1BQ2 '26
$740MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Octagon Capital Advisors 13F FAQ

What does Octagon Capital Advisors own?

Octagon Capital Advisors reported 25 stocks worth $740M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are DNTH (20.1%), ABVX (13.3%) and DFTX (12.9%). The table above lists every position in the filing (the top 10 without an account).

What did Octagon Capital Advisors buy and sell in Q3 2026?

Compared with Q2 2026: 2 new positions, 1 added to, 13 trimmed and 3 sold out. New positions include OBX and TNGX. It sold all of ALMS, SMMT and CNTX.

When will Octagon Capital Advisors file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Octagon Capital Advisors's portfolio worth?

The Q3 2026 filing reports $740M in US stocks ($751M including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.